0001209191-24-001042.txt : 20240105 0001209191-24-001042.hdr.sgml : 20240105 20240105164151 ACCESSION NUMBER: 0001209191-24-001042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Julie CENTRAL INDEX KEY: 0001883722 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40288 FILM NUMBER: 24516811 MAIL ADDRESS: STREET 1: C/O DESIGN THERAPEUTICS, INC. STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Design Therapeutics, Inc. CENTRAL INDEX KEY: 0001807120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823929248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 858-293-4900 MAIL ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-02 0 0001807120 Design Therapeutics, Inc. DSGN 0001883722 Burgess Julie C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 0 1 0 0 Chief Accounting Officer 0 Stock Option (right to buy) 2.54 2024-01-02 4 A 0 110000 0.00 A 2034-01-01 Common Stock 110000 110000 D The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months. /s/ Mustapha Parekh, Attorney-in-Fact 2024-01-05